| Year |
Citation |
Score |
| 2016 |
Ding S, Zhang J, Tian Y, Huang B, Yuan Y, Liu C. Magnesium modification up-regulates the bioactivity of bone morphogenetic protein-2 upon calcium phosphate cement via enhanced BMP receptor recognition and Smad signaling pathway. Colloids and Surfaces. B, Biointerfaces. 145: 140-151. PMID 27156155 DOI: 10.1016/j.colsurfb.2016.04.045 |
0.398 |
|
| 2016 |
Huang B, Yuan Y, Li T, Ding S, Zhang W, Gu Y, Liu C. Facilitated receptor-recognition and enhanced bioactivity of bone morphogenetic protein-2 on magnesium-substituted hydroxyapatite surface. Scientific Reports. 6: 24323. PMID 27075233 DOI: 10.1038/srep24323 |
0.317 |
|
| 2009 |
Lloyd SA, Yuan YY, Simske SJ, Riffle SE, Ferguson VL, Bateman TA. Administration of high-dose macrophage colony-stimulating factor increases bone turnover and trabecular volume fraction. Journal of Bone and Mineral Metabolism. 27: 546-54. PMID 19326045 DOI: 10.1007/S00774-009-0071-9 |
0.644 |
|
| 2008 |
Lloyd SA, Yuan YY, Kostenuik PJ, Ominsky MS, Lau AG, Morony S, Stolina M, Asuncion FJ, Bateman TA. Soluble RANKL induces high bone turnover and decreases bone volume, density, and strength in mice. Calcified Tissue International. 82: 361-72. PMID 18465074 DOI: 10.1007/S00223-008-9133-6 |
0.674 |
|
| 2008 |
Yuan YY, Kostenuik PJ, Ominsky MS, Morony S, Adamu S, Simionescu DT, Basalyga DM, Asuncion FJ, Bateman TA. Skeletal deterioration induced by RANKL infusion: a model for high-turnover bone disease. Osteoporosis International : a Journal Established as Result of Cooperation Between the European Foundation For Osteoporosis and the National Osteoporosis Foundation of the Usa. 19: 625-35. PMID 18038244 DOI: 10.1007/S00198-007-0509-7 |
0.664 |
|
| 2004 |
Yuan Y, Ferguson VL, Simske SJ, Bateman TA. Low dose administration of macrophage colony-stimulating factor in mice. Biomedical Sciences Instrumentation. 40: 93-8. PMID 15133941 |
0.639 |
|
| Show low-probability matches. |